Postoperative Pain Management Market Driven by Growing Business Outlook & Technology

Postoperative Discomfort Management seeks to reduce patient pain, promote early activity, reduce secondary or long-term pain, and prevent acute pain from progressing to long-term chronic pain. Physiotherapy is essential for pain treatment following surgery. Physical therapy helps patients return to normal daily activities while also increasing function. Physiotherapists are extensively versed in manual physiotherapy procedures, manual exercise techniques, alternative therapies, and pain management in general. They provide a regular and complementary therapy, as well as acute and chronic pain management and stress management. While many patients have effective postoperative pain management at the time of surgery, others may need extra therapies to ease pain or control symptoms.

Pfizer Inc., DURECT Corporation, Bayer AG, A.P. Pharma, Inc., Novartis AG, and BTG International Ltd. are among the major players in the worldwide postoperative pain treatment market.

Increasing rates of post-surgery traumas and pain, together with increased demand for pain-relieving medications, are likely to drive expansion in the postoperative pain management market throughout the forecast period.

Furthermore, increasing incidences of joint pain among the elderly are likely to complement growth in the postoperative pain management market during the forecast period.

Due to the prevalence of the COVID-19 pandemic, the worldwide postoperative pain management market went off a cliff in the second quarter of 2020. Given the virus's spread, total surgical operations in the healthcare industry have decreased significantly. Furthermore, rising rates of joint pain among COVID-19 patients have opened up new potential for market participants.